Dear Colleague,
You may be interested in the most recent commentary from the DeVos Center for Religion and Civil Society:
Melanie Israel, Research Associate
In September 2000, the United States Food and Drug Administration approved the use of mifepristone—an abortion pill—commonly known as RU-486 or its brand name, Mifeprex. Its entrance on the U.S. market was mired in controversy for reasons including its approval process, inadequate oversight of adverse effects as a result of its use, and the simple fact that it is an abortifacient. The drug remains no less contentious 20 years later. The annual percentage of chemical abortions grows larger every year. Pro-abortion activists, as well as state and federal lawmakers, are agitating to remove safety standards guiding the drug’s usage—or even make it available over the counter. U.S. policymakers must address the alarming impact of this dangerous drug.
Emilie Kao, Director
Truly, Amazon is a miracle of modern society. But when the world’s largest online retailer makes itself the arbiter of a new cultural orthodoxy, it quickly becomes one of the most insidious instruments for tyranny.
The Daily Signal
Jared Eckert, Research Assistant
Just a week after Arkansas Gov. Asa Hutchinson signed bills protecting women’s sports and medical conscience protections from being forced to bend to progressive gender ideology, he now has the chance to sign yet another pro-science bill that would protect children from harmful surgical and hormonal interventions on their bodies in the name of “gender affirmation” and “transgender medicine.”
Nicole Russell, Contributor
South Dakota Gov. Kristi Noem should have honored the will of her constituents, taken the risk of signing the bill, and joined the myriad of other organizations already working to ensure fairness for women and girls.
Sincerely,
DeVos Center for Religion and Civil Society
Institute for Family, Community and Opportunity
The Heritage Foundation